The existence of the association between the transplantation of MSCs constitutively secreting IL-18 and ameliorated T-cell infiltration and continued antitumor responses have indicated that IL-18 can be an operative and rationally adoptive immunotherapy for malignant tumors (74). Here, IL18 is linked to cancer.